PURPOSEFUL. PRIVATE.

Results-focused • Safety-conscious • WhatsApp-first ordering

BioHack88 Talk to us
Collection — Peptides
V-Med Retatrutide 30MG
BioHack88 curated collection 18+ only
Peptides

V-Med Retatrutide 30MG

VMED
R1,799.00
Available to discuss & order

Retatrutide is an investigational once-weekly injection by Eli Lilly currently in Phase 3 clinical trials. Often called a "Triple-G" agonist, it uniquely targets three metabolic hormones: GLP-1, GIP, and glucagon. In trials, it has yielded an unprecedented average weight loss of up to 24-30%

PRIVATE ORDERING

Discuss this product.

The product name, SKU and current website price will be pre-filled into WhatsApp so you can complete the conversation directly with BioHack88.

Discuss & order on WhatsApp Open WhatsApp catalogue →
Purpose first Understand why it fits before adding it.
Private conversation Complete the order directly on WhatsApp.
Clear pricing Website pricing remains visible while you browse.
PRODUCT OVERVIEW

Details without the noise.

Retatrutide is an investigational once-weekly injection by Eli Lilly currently in Phase 3 clinical trials. Often called a "Triple-G" agonist, it uniquely targets three metabolic hormones: GLP-1, GIP, and glucagon. In trials, it has yielded an unprecedented average weight loss of up to 24-30%